Rare
lephants
Screener
Toggle theme
Perrigo Company plc
PRGO
·
Healthcare, Drug Manufacturers - General, Ireland
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
Total Cash from Operations:
$3.06B
Line Item
Value
% of Total
Dividends Paid
$91.1M
3.0%
Stock Repurchases
$191.5M
6.3%
Other Financing
$2.72B
88.9%
Net Cash Flow
$56.4M
1.8%
Download CSV